Onco Nano Medicine Announces Promotion of Kartik Krishnan, Md, Ph D, To President and Head of Research & Development

Nov 06, 2023•over 1 year ago

Position

Chief Operating Officer

Company

OncoNano Medicine

Melissa Paoloni

SouthlakeTherapeuticsMedicalBiotechnologyHealth Care

Description

OncoNano Medicine, Inc. today announced that Kartik Krishnan, M.D., Ph.D., has been promoted to the new role of President and Head of Research and Development. He has served as Chief Medical Officer since 2022

Company Information

Company

OncoNano Medicine

Location

Southlake, Texas, United States

About

OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents. Our lead program, ONM-100, targets tumor acidosis to accurately differentiate cancer from healthy tissue for use in surgery.

TalentWatch™ Score

High Hiring Activity

Executive Opportunity Analysis

Get personalized insights on executive opportunities

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Related People

Melissa hidden

hidden

Kartik hidden